Explore the words cloud of the SAL ETHVI project. It provides you a very rough idea of what is the project "SAL ETHVI" about.
The following table provides information about the project.
ZAKLAD BADAWCZO-WDROZENIOWY OSRODKASALMONELLA IMMUNOLAB SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA
|Coordinator Country||Poland [PL]|
|Total cost||71˙429 €|
|EC max contribution||50˙000 € (70%)|
1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
2. H2020-EU.3.2. (SOCIETAL CHALLENGES - Food security, sustainable agriculture and forestry, marine, maritime and inland water research, and the bioeconomy)
|Duration (year-month-day)||from 2016-01-01 to 2016-05-31|
Take a look of project's partnership.
|1||ZAKLAD BADAWCZO-WDROZENIOWY OSRODKASALMONELLA IMMUNOLAB SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA||PL (GDYNIA)||coordinator||50˙000.00|
|2||NatVet sp. z o. o.||PL (Gdansk)||participant||0.00|
Salmonella species (also called serovars) are important zoonotic pathogens that cause gastrointestinal disease in humans and animals. Poultry products contaminated with these pathogens are one of the major sources of human Salmonella infections worldwide. Salmonella Enteritidis and Typhimurium are the serovars most frequently associated with human food poisoning (78.3 % of all cases in 2003). The serovars of Salmonella having places three to five are Virchow, Infantis and Hadar. Vaccination of chickens, along with other intervention measures in the overall biosecurity system of chicken farms, is an important strategy that is currently being used to reduce the levels of Salmonella in poultry flocks, which will ultimately lead to lower rates of human infections. However, despite numerous studies that have been performed, there is still a need for safer, well-defined Salmonella vaccines. At Immunolab we invented SAL ETHVI – innovative vaccine against above listed 5 serovars of Salmonella. We also breakthrough the technology for the vaccine production in a way that allows any configuration of serotypes, therefore if there is a need for a vaccine against another serovar, its production will be very easy. The end users of the vaccine will be poultry breeders, namely hens and broilers flocks owners. The unique features of our vaccine constituting our competitive adventage comprise : (1) easy application ; (2) low price ; (3) immediate vaccination upon hatching; (4) no risk of bacteria activation and spreading. We have filled a patent application for the technology and upon the vaccine registration and certification, we aim to commercialize it at the broilers markets of the biggest European poultry meat producers: Poland, Germany, France, the Netherlands, United Kingdom and Russia. We are applying for the SME Instrument Phase 1, aiming to complete the feasibility study and a business plan including industry value-chain mapping, market sizing and critical risks assessment.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SAL ETHVI" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "SAL ETHVI" are provided by the European Opendata Portal: CORDIS opendata.
Rapid on-site detection of Mycotoxin in wheatRead More
Eco-innovative and fully integrated microbial rapid monitoring system - PROTECTING shelf life, food safety and quality throughout the DAIRY supply chain, from farm to fork.Read More
Active packaging for extending lifespan of champignonRead More